Caprion-HistoGeneX Acquires Clinical Logistics Inc., a Virtual Central Specimen Management CRO, and Expands its Support of Clinical Trials Specimen Logistics

PR87500

MONTREAL, Jan. 7, 2021 /PRNewswire=KYODO JBN/ --

Caprion-HistoGeneX, a leading global contract research laboratory services

provider backed by Arsenal Capital Partners, announced today the acquisition of

Clinical Logistics Inc. ("CLI"), a Virtual Central Specimen Management CRO

based in Halifax, Canada. The acquisition enables Caprion-HistoGeneX to broaden

its specimen logistics services to support the global clinical trial needs of

its pharma and biotech customers better. Focused on critical specialty

specimens with complex processing requirements such as limited stability and/or

real-time testing needs, CLI offers integrated, customizable solutions combined

with kitting and specimen logistic services for timely specimen delivery.

Logo -

https://mma.prnewswire.com/media/1396104/Caprion_Biosciences_Caprion_HistoGeneX_Logo.jpg

Logo -

https://mma.prnewswire.com/media/1396106/Caprion_Biosciences_Caprion_ClinicalLogistics_Logo1.jpg

CLI was founded in 2002 and has supported clinical trials in over 50 countries.

The company has earned a reputation for quality and customer service excellence

with some of the largest pharmaceutical companies, biotechs and CROs. Answering

an unmet need in the marketplace for high quality handling of critical samples

from clinical trial sites to the laboratory, CLI is positioned as a key player

in clinical trial logistics with a focus on specialty specimens. CLI's services

also include logistics and kitting for pharmacokinetic / pharmacodynamic

(PK/PD) and pharmacogenomics (PG) biomarkers. "We are excited to be a part of

the Caprion-HistoGeneX organization. CLI will be able to leverage the broad

capabilities and global footprint of Caprion-HistoGeneX to continue to improve

and rapidly globalize our Central Specimen Management services" said Raymond

Mah, Co-CEO and Co-Founder of CLI.

Recently recommended for ISO 13485 certification, CLI offers customized

specimen collection kits, shipment assistance at investigator sites, as well as

timely specimen shipping coordination & tracking, resulting in high recovery of

specialty specimens from investigator sites, optimal specimen integrity and

timely analyses. With its Virtual Central Specimen Management platform, CLI

eliminates the need for investigator sites to transfer specimens to a central

storage facility before their arrival at third-party testing labs. As a centralized

point of contact during clinical trials, CLI increases specimen handling

consistency and minimizes the burden of specimen tracking discrepancies.

"Caprion-HistoGeneX is excited to expand its specimen logistics and management

solutions, reinforcing our end-to-end services and ensuring specimen integrity

from collection to analysis. These services will be scaled through our

worldwide network of laboratories to provide comprehensive support to global

clinical trial sites and help alleviate common daily challenges that our

clients are facing with their complex clinical operations."  said Martin

LeBlanc, CEO of Caprion-HistoGeneX.

About Caprion-HistoGeneX      

Caprion-HistoGeneX is a leading provider of specialized precision medicine

laboratory services to the biopharmaceutical industry. Leveraging its

integrated analytical platforms in immunology, histopathology, proteomics, and

genomics, Caprion-HistoGeneX supports the entire drug development cycle, from

discovery to late-stage clinical trials. The company operates globally with 8

facilities located in Canada, USA, Belgium, Australia, and China.

For more information:  www.caprion.com  and  www.histogenex.com

About Clinical Logistics Inc.      

Clinical Logistics Inc. (CLI) is a contract research organization (CRO)

providing clinical trial services to global pharmaceutical and biotech

companies. The services include the provision of specimen collection supplies,

production of customized specimen identification labels and kits, and specimen

shipping coordination, management, and tracking.

For more information: www.clinicallogistics.net

About Arsenal Capital Partners

Arsenal is a leading private equity firm that specializes in investments in

middle-market healthcare and industrials companies. Since its inception in

2000, Arsenal has raised institutional equity investment funds of $5.3 billion,

has completed more than 200 platform and add-on investments, and achieved more

than 30 realizations. Arsenal invests in industry sectors in which the firm has

significant prior knowledge and experience. The firm works with management

teams to build strategically important companies with leading market positions,

high growth, and high value-add.

For more information: www.arsenalcapital.com

SOURCE: Caprion Biosciences Inc.

Media Contact: Caprion-HistoGeneX, Guylaine Galipeau, Global Marketing

Director, Caprion-HistoGeneX, ggalipeau@caprion.com